Willis Johnson & Associates’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-10,000
Closed -$49.1K – 169
2025
Q1
$49.1K Hold
10,000
– – ﹤0.01% 165
2024
Q4
$50.7K Hold
10,000
– – ﹤0.01% 153
2024
Q3
$68.9K Hold
10,000
– – 0.01% 165
2024
Q2
$74.1K Hold
10,000
– – 0.01% 150
2024
Q1
$73K Hold
10,000
– – 0.01% 154
2023
Q4
$62K Hold
10,000
– – 0.01% 136
2023
Q3
$40.8K Buy
+10,000
New +$39K ﹤0.01% 122

Other funds holding ARDX

Willis Johnson & Associates's ARDX Position: Q2 2025 in Review

Willis Johnson & Associates sold out of Ardelyx (ARDX) in Q2 2025, closing a stake of 10,000 shares — an estimated $49.1K sold.

Willis Johnson & Associates first reported a position in ARDX in Q3 2023 and held it in 7 quarters. The position peaked at $74.1K in Q2 2024. 206 funds tracked by Wall St. Rank hold ARDX as of Q2 2025.

  • Willis Johnson & Associates reported no remaining Ardelyx position as of Q2 2025 after selling out during the quarter.
  • Willis Johnson & Associates sold 10,000 Ardelyx shares in Q2 2025, an estimated $49.1K.
  • Willis Johnson & Associates first reported a position in Ardelyx in Q3 2023 and held it in 7 quarters.
  • Willis Johnson & Associates's Ardelyx position peaked at $74.1K in Q2 2024.
  • 206 funds tracked by Wall St. Rank held Ardelyx as of Q2 2025.

Based on Willis Johnson & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.